Thompson, Iii; Lorin A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thompson, Iii; Lorin A..The latest application filed is for "p38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd".

Company Profile

14.24.41

Thompson, Iii; Lorin A. - Cohasset MA
Thompson, III; Lorin A. - Higganum CT
Thompson III, Lorin A. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd App 20220282254 - Cacace; Angela Marie ; et al.	2022-09-08
Macrocyclic Azolopyridine Derivatives As Eed And Prc2 Modulators App 20220160686 - Efremov; Ivan Viktorovich ; et al.	2022-05-26
P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd App 20220133704 - Cacace; Angela Marie ; et al.	2022-05-05
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Grant 11,291,659 - Cacace , et al. April 5, 2	2022-04-05
Selective Nr2b Antagonists App 20210121453 - King; Dalton ; et al.	2021-04-29
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Grant 10,973,805 - Efremov , et al. April 13, 2	2021-04-13
P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd App 20200383963 - CACACE; Angela Marie ; et al.	2020-12-10
Macrocyclic Azolopyridine Derivatives As Eed And Prc2 Modulators App 20200360353 - EFREMOV; Ivan Viktorovich ; et al.	2020-11-19
Use Of P38 Inhibitors To Reduce Expression Of Dux4 App 20200332291 - CACACE; Angela Marie ; et al.	2020-10-22
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20200297742 - Thompson, III; Lorin A. ; et al.	2020-09-24
Selective Nr2b Antagonists App 20200163949 - King; Dalton ; et al.	2020-05-28
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Grant 10,537,560 - Cacace , et al. Ja	2020-01-21
Selective Nr2b Antagonists App 20190314358 - King; Dalton ; et al.	2019-10-17
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatme App 20190314392 - Thompson, III; Lorin A. ; et al.	2019-10-17
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Grant 10,342,786 - Cacace , et al. July 9, 2	2019-07-09
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20190125770 - Thompson, III; Lorin A. ; et al.	2019-05-02
Selective Nr2b Antagonists App 20190117638 - King; Dalton ; et al.	2019-04-25
P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd App 20190105312 - CACACE; Angela Marie ; et al.	2019-04-11
P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd App 20190105311 - CACACE; Angela Marie ; et al.	2019-04-11
Selective Nr2b Antagonists App 20180250283 - King; Dalton ; et al.	2018-09-06
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20180250316 - Thompson, III; Lorin A. ; et al.	2018-09-06
Selective Nr2b Antagonists App 20180110766 - King; Dalton ; et al.	2018-04-26
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20180104265 - Thompson, III; Lorin A. ; et al.	2018-04-19
Selective Nr2b Antagonists App 20180000807 - King; Dalton ; et al.	2018-01-04
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20170340653 - Thompson, III; Lorin A. ; et al.	2017-11-30
Selective NR2B Antagonists App 20170258777 - King; Dalton ; et al.	2017-09-14
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20170216325 - Thompson, III; Lorin A. ; et al.	2017-08-03
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20170065573 - Thompson, III; Lorin A. ; et al.	2017-03-09
Selective NR2B Antagonists App 20160081995 - King; Dalton ; et al.	2016-03-24
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20160030456 - Thompson, III; Lorin A. ; et al.	2016-02-04
Selective NR2B antagonists Grant 9,221,796 - King , et al. December 29, 2	2015-12-29
Compounds For The Reduction Of Beta-amyloid Production App 20150336975 - Boy; Kenneth M. ; et al.	2015-11-26
(R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- yl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disorders Grant 9,187,506 - Thompson, III , et al. November 17, 2	2015-11-17
(r)-3-((3s,4s)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenz- Yl)pyrrolidin-2-one And Its Prodrugs For The Treatment Of Psychiatric Disorders App 20150191496 - Thompson, III; Lorin A. ; et al.	2015-07-09
Selective NR2B Antagonists App 20150191452 - King; Dalton ; et al.	2015-07-09
Compounds For The Reduction Of Beta-amyloid Production App 20150152089 - Boy; Kenneth M. ; et al.	2015-06-04
Compounds for the reduction of .beta.-amyloid production Grant 8,710,061 - Boy , et al. April 29, 2	2014-04-29
Compounds for the reduction of beta-amyloid production Grant 8,637,523 - Boy , et al. January 28, 2	2014-01-28
Compounds for the reduction of beta-amyloid production Grant 8,637,525 - Boy , et al. January 28, 2	2014-01-28
Compounds for the reduction of beta-amyloid production Grant 8,604,024 - Thompson, III , et al. December 10, 2	2013-12-10
Compounds for the reduction of .beta.-amyloid production Grant 8,486,952 - Boy , et al. July 16, 2	2013-07-16
Compounds For The Reduction Of Beta-amyloid Production App 20130178462 - Boy; Kenneth M. ; et al.	2013-07-11
Compounds For The Reduction Of Beta-amyloid Production App 20130131051 - THOMPSON, III; LORIN A. ; et al.	2013-05-23
Compounds For The Reduction Of Beta-amyloid Production App 20130030011 - BOY; KENNETH M. ; et al.	2013-01-31
Bicyclic compounds for the reduction of beta-amyloid production Grant 8,349,880 - Marcin , et al. January 8, 2	2013-01-08
Compounds For The Reduction Of Beta-amyloid Production App 20120184565 - Boy; Kenneth M. ; et al.	2012-07-19
Compounds For The Reduction Of Beta-amyloid Production App 20120028994 - Boy; Kenneth M. ; et al.	2012-02-02
Compounds For The Reduction Of Beta-amyloid Production App 20110212937 - Boy; Kenneth M. ; et al.	2011-09-01
Isophthalates as beta-secretase inhibitors Grant 7,981,913 - Thompson, III , et al. July 19, 2	2011-07-19
Substituted tetrahydroisoquinolines as .beta.-secretase inhibitors Grant 7,902,218 - Thompson, III , et al. March 8, 2	2011-03-08
Bicyclic Compounds for the Reduction of Beta-Amyloid Production App 20110015175 - Marcin; Lawrence R. ; et al.	2011-01-20
Novel Isophthalates As Beta-secretase Inhibitors App 20100222581 - Thompson, III; Lorin A. ; et al.	2010-09-02
Isophthalates as beta-secretase inhibitors Grant 7,745,470 - Thompson, III , et al. June 29, 2	2010-06-29
Acyl guanidines as beta-secretase inhibitors Grant 7,612,069 - Gerritz , et al. November 3, 2	2009-11-03
Indole acetic acid acyl guanidines as .beta.-secretase inhibitors Grant 7,601,751 - Thompson, III , et al. October 13, 2	2009-10-13
Gamma-lactams as beta-secretase inhibitors Grant 7,557,137 - Decicco , et al. July 7, 2	2009-07-07
Gamma-lactams as beta-secretase inhibitors Grant 7,388,007 - Thompson, III , et al. June 17, 2	2008-06-17
Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production App 20020052360 - Olson, Richard E. ; et al.	2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.